AVDL
Price
$9.71
Change
+$0.27 (+2.86%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
1.53B
61 days until earnings call
PAHC
Price
$24.08
Change
+$0.19 (+0.80%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
523.71M
82 days until earnings call
Interact to see
Advertisement

AVDL vs PAHC

Header iconAVDL vs PAHC Comparison
Open Charts AVDL vs PAHCBanner chart's image
Avadel Pharmaceuticals
Price$9.71
Change+$0.27 (+2.86%)
Volume$21.31K
Capitalization1.53B
Phibro Animal Health
Price$24.08
Change+$0.19 (+0.80%)
Volume$200
Capitalization523.71M
AVDL vs PAHC Comparison Chart
Loading...
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVDL vs. PAHC commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a Hold and PAHC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (AVDL: $9.44 vs. PAHC: $23.89)
Brand notoriety: AVDL: Notable vs. PAHC: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVDL: 89% vs. PAHC: 81%
Market capitalization -- AVDL: $1.53B vs. PAHC: $523.71M
AVDL [@Pharmaceuticals: Other] is valued at $1.53B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than AVDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 3 TA indicator(s) are bullish while PAHC’s TA Score has 5 bullish TA indicator(s).

  • AVDL’s TA Score: 3 bullish, 5 bearish.
  • PAHC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than AVDL.

Price Growth

AVDL (@Pharmaceuticals: Other) experienced а +2.39% price change this week, while PAHC (@Pharmaceuticals: Other) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +79.53%. For the same industry, the average monthly price growth was +16.37%, and the average quarterly price growth was +68.04%.

Reported Earning Dates

AVDL is expected to report earnings on Aug 06, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+79.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVDL($1.53B) has a higher market cap than PAHC($524M). PAHC YTD gains are higher at: 14.875 vs. AVDL (-10.181). PAHC has higher annual earnings (EBITDA): 83.7M vs. AVDL (-149.12M). AVDL has more cash in the bank: 105M vs. PAHC (92.5M). AVDL has less debt than PAHC: AVDL (2.62M) vs PAHC (513M). PAHC has higher revenues than AVDL: PAHC (982M) vs AVDL (28M).
AVDLPAHCAVDL / PAHC
Capitalization1.53B524M292%
EBITDA-149.12M83.7M-178%
Gain YTD-10.18114.875-68%
P/E RatioN/A34.11-
Revenue28M982M3%
Total Cash105M92.5M114%
Total Debt2.62M513M1%
FUNDAMENTALS RATINGS
AVDL vs PAHC: Fundamental Ratings
AVDL
PAHC
OUTLOOK RATING
1..100
5721
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
9777
SMR RATING
1..100
9461
PRICE GROWTH RATING
1..100
5741
P/E GROWTH RATING
1..100
4892
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (23) in the Pharmaceuticals Major industry is somewhat better than the same rating for AVDL (77) in the Medical Specialties industry. This means that PAHC’s stock grew somewhat faster than AVDL’s over the last 12 months.

PAHC's Profit vs Risk Rating (77) in the Pharmaceuticals Major industry is in the same range as AVDL (97) in the Medical Specialties industry. This means that PAHC’s stock grew similarly to AVDL’s over the last 12 months.

PAHC's SMR Rating (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for AVDL (94) in the Medical Specialties industry. This means that PAHC’s stock grew somewhat faster than AVDL’s over the last 12 months.

PAHC's Price Growth Rating (41) in the Pharmaceuticals Major industry is in the same range as AVDL (57) in the Medical Specialties industry. This means that PAHC’s stock grew similarly to AVDL’s over the last 12 months.

AVDL's P/E Growth Rating (48) in the Medical Specialties industry is somewhat better than the same rating for PAHC (92) in the Pharmaceuticals Major industry. This means that AVDL’s stock grew somewhat faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVDLPAHC
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 9 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIOTX22.88N/A
N/A
Victory Pioneer Core Equity A
DHLYX33.10N/A
N/A
Diamond Hill Large Cap Y
OIOIX15.41N/A
N/A
AXS Income Opportunities I
TWGGX11.73N/A
N/A
American Century Focused Global Gr Inv
WIGOX4.37-0.01
-0.23%
Wasatch Global Opportunities Instl

AVDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVDL has been loosely correlated with RMTI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AVDL jumps, then RMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
+1.40%
RMTI - AVDL
34%
Loosely correlated
-3.06%
PRGO - AVDL
26%
Poorly correlated
-1.10%
PAHC - AVDL
25%
Poorly correlated
-0.35%
RDY - AVDL
24%
Poorly correlated
+5.29%
LIEN - AVDL
24%
Poorly correlated
+0.44%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-0.35%
PBH - PAHC
49%
Loosely correlated
-0.20%
AMRX - PAHC
44%
Loosely correlated
-0.55%
ZTS - PAHC
40%
Loosely correlated
+0.01%
VTRS - PAHC
38%
Loosely correlated
-1.63%
ELAN - PAHC
35%
Loosely correlated
-0.07%
More